S&P 500
(1.08%) 5 102.96 points
Dow Jones
(0.43%) 38 250 points
Nasdaq
(2.08%) 15 936 points
Oil
(0.08%) $83.64
Gas
(-1.16%) $1.619
Gold
(0.28%) $2 349.10
Silver
(-0.53%) $27.21
Platinum
(0.16%) $921.95
USD/EUR
(0.33%) $0.935
USD/NOK
(0.68%) $11.03
USD/GBP
(0.15%) $0.800
USD/RUB
(-0.32%) $91.87

Realtime updates for Ocugen Inc [OCGN]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
100.00%
return 9.47%
SELL
100.00%
return -10.94%
Last Updated26 Apr 2024 @ 15:47

6.78% $ 1.260

BUY 103636 min ago

@ $0.657

Issued: 14 Feb 2024 @ 15:30


Return: 91.93%


Previous signal: Feb 14 - 09:30


Previous signal: Sell


Return: 6.16 %

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 15:47):
Profile picture for Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD...

Stats
Today's Volume 4.93M
Average Volume 9.39M
Market Cap 324.23M
EPS $0 ( 2024-04-02 )
Next earnings date ( $-0.0600 ) 2024-05-03
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -4.85
ATR14 $0.00900 (0.71%)
Insider Trading
Date Person Action Amount type
2024-04-16 Qamar Huma Buy 308 465 Option (Right to Buy)
2024-03-18 Qamar Huma Sell 0 Common Stock
2023-09-15 Breininger Michael Buy 0
2024-01-03 Musunuri Shankar Sell 180 204 Common Stock
2024-01-03 Upadhyay Arun Sell 41 633 Common Stock
INSIDER POWER
65.17
Last 96 transactions
Buy: 10 862 012 | Sell: 2 992 475

Volume Correlation

Long: 0.04 (neutral)
Short: -0.06 (neutral)
Signal:(47.11) Neutral

Ocugen Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ocugen Inc Correlation - Currency/Commodity

The country flag 0.59
( weak )
The country flag 0.51
( weak )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.17
( neutral )

Ocugen Inc Financials

Annual 2023
Revenue: $6.04M
Gross Profit: $5.33M (88.34 %)
EPS: $-0.260
FY 2023
Revenue: $6.04M
Gross Profit: $5.33M (88.34 %)
EPS: $-0.260
FY 2022
Revenue: $0
Gross Profit: $-1.07M (0.00 %)
EPS: $-0.360
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-0.300

Financial Reports:

No articles found.

Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators